Ropivacainhydrochlorid Sintetica (Ropivacaine Sintetica 2 mg/ml Stungulyf, lausn) Stungulyf, lausn 2 mg/ml Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

ropivacainhydrochlorid sintetica (ropivacaine sintetica 2 mg/ml stungulyf, lausn) stungulyf, lausn 2 mg/ml

sintetica gmbh - ropivacainum hýdróklóríð - stungulyf, lausn - 2 mg/ml

Eucreas União Europeia - islandês - EMA (European Medicines Agency)

eucreas

novartis europharm limited - vildagliptin, kvarta stutt og long-term - sykursýki, tegund 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) União Europeia - islandês - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, kvarta stutt og long-term - sykursýki, tegund 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 fyrir tiltæk gögn um mismunandi samsetningar).

Invokana União Europeia - islandês - EMA (European Medicines Agency)

invokana

janssen-cilag international nv - canagliflozin - sykursýki, tegund 2 - lyf notuð við sykursýki - invokana is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:as monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 og 5.

Jalra União Europeia - islandês - EMA (European Medicines Agency)

jalra

novartis europharm limited - vildagliptin - sykursýki, tegund 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 fyrir tiltæk gögn um mismunandi samsetningar).

Trulicity União Europeia - islandês - EMA (European Medicines Agency)

trulicity

eli lilly nederland b.v. - dúlaglútíð - sykursýki, tegund 2 - drugs used in diabetes, blood glucose lowering drugs, excl. insulins - trulicity is indicated for the treatment of patients 10 years and above with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. fyrir rannsókn árangri með tilliti til sturtu, áhrif á blóðsykursstjórnun og hjarta viðburði, og íbúa rannsakað, sjáðu kafla 4. 4, 4. 5 og 5.

Talmanco (previously Tadalafil Generics) União Europeia - islandês - EMA (European Medicines Agency)

talmanco (previously tadalafil generics)

viatris limited - tadalafil - háþrýstingur, lungnabólga - Þvaglát - talmanco er ætlað í fullorðnir fyrir meðferð lungum slagæð háan blóðþrýsting (pah) flokkast sem hagnýtur ii og iii, til að bæta æfing getu. verkun hefur verið sýnd í sjálfvakta pah (ipah) og í pah í tengslum við krabbameinsvaldandi sjúkdóma.

Minirin Frostþurrkuð tafla 60 míkróg Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

minirin frostþurrkuð tafla 60 míkróg

ferring lægemidler a/s - desmopressinum acetat - frostþurrkuð tafla - 60 míkróg

Minirin Frostþurrkuð tafla 240 míkróg Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

minirin frostþurrkuð tafla 240 míkróg

ferring lægemidler a/s - desmopressinum acetat - frostþurrkuð tafla - 240 míkróg

Minirin Frostþurrkuð tafla 120 míkróg Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

minirin frostþurrkuð tafla 120 míkróg

ferring lægemidler a/s - desmopressinum acetat - frostþurrkuð tafla - 120 míkróg